Cozzi, Giacomo
Scagnellato, Laura
Lorenzin, Mariagrazia
Savarino, Edoardo
Zingone, Fabiana http://orcid.org/0000-0003-1133-1502
Ometto, Francesca
Favero, Marta http://orcid.org/0000-0002-1079-6669
Doria, Andrea http://orcid.org/0000-0003-0548-4983
Vavricka, Stephan R.
Ramonda, Roberta http://orcid.org/0000-0002-9683-8873
Article History
Accepted: 19 May 2023
First Online: 29 June 2023
Competing interests
: G.C., L.S., F.O. and M.F. declare no competing interests; M.L. has received consulting fees from AbbVie; E.S. has served as a speaker for AbbVie, Agave, AGPharma, Alfasigma, Aurora Pharma, CaDiGroup, Celltrion, Dr Falk, EG Stada Group, Fenix Pharma, Fresenius Kabi, Galapagos, Janssen, JB Pharmaceuticals, Innovamedica/Adacyte, Malesci, Mayoly Biohealth, Omega Pharma, Pfizer, Reckitt Benckiser, Sandoz, SILA, Sofar, Takeda, Tillots and Unifarco, as a consultant for AbbVie, Agave, Alfasigma, Biogen, Bristol-Myers Squibb, Celltrion, Diadema Farmaceutici, Dr Falk, Fenix Pharma, Fresenius Kabi, Janssen, JB Pharmaceuticals, Merck & Co, Reckitt Benckiser, Regeneron, Sanofi, SILA, Sofar, Synformulas GmbH, Takeda and Unifarco, and has received research support from Pfizer, Reckitt Benckiser, SILA, Sofar, Unifarco and Zeta Farmaceutici; F.Z. has served as speaker for EG Stada Group, Fresenius Kabi, Janssen, Pfizer, Takeda, Unifarco and Malesci, and has served as a consultant for Galapagos; A.D. has received consulting fees from GSK, Pfizer, AstraZeneca, Celgene, Eli Lilly and Baxalta; S.R.V. has received consulting fees, speaker’s honoraria and unrestricted research grants from Abbott, Alfasigma, Amgen, Arenapharm, BMS, Falk Pharma GmbH, Ferring Pharmaceuticals, Gilead, iQuone, Janssen, MSD, Permamed, Pfizer, Sanofi-Aventis, Schwabe Pharma, Takeda, Tillotts, UCB and Vifor; R.R. has received honoraria and speaker fees from Novartis, AbbVie, Pfizer, MSD and Janssen.